CL
IOVA icon

Choreo LLC’s Iovance Biotherapeutics IOVA Stock Holding History

Choreo LLC’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$54.9K Buy
13,197
+128
+1% +$486 ﹤0.01% 1636
2026
Q1 		$45.9K Hold
13,069
– – ﹤0.01% 1569
2025
Q4 		$36.2K Buy
13,069
+2,978
+30% +$6.89K ﹤0.01% 1542
2025
Q3 		$21.9K Sell
10,091
-21,745
-68% -$51.3K ﹤0.01% 1562
2025
Q2 		$54.8K Buy
31,836
+6,641
+26% +$16.5K ﹤0.01% 1482
2025
Q1 		$83.9K Sell
25,195
-5,250
-17% -$27.1K ﹤0.01% 1378
2024
Q4 		$218K Buy
30,445
+8,625
+40% +$79.9K ﹤0.01% 1379
2024
Q3 		$204K Buy
21,820
+7,466
+52% +$70.7K ﹤0.01% 1458
2024
Q2 		$116K Buy
+14,354
New +$154K ﹤0.01% 1386

Other funds holding IOVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Choreo LLC's IOVA Position: Q2 2026 in Review

Choreo LLC increased its Iovance Biotherapeutics (IOVA) stake by 0.98% in Q2 2026, buying an estimated $486 and bringing the position to 13,197 shares worth $54.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1636.

Choreo LLC first reported a position in IOVA in Q2 2024 and has held it in 9 quarters since. The position peaked at $218K in Q4 2024. 292 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.

  • Choreo LLC held 13,197 shares of Iovance Biotherapeutics worth $54.9K as of Q2 2026.
  • Choreo LLC bought 128 Iovance Biotherapeutics shares in Q2 2026, an estimated $486.
  • Iovance Biotherapeutics made up ﹤0.01% of Choreo LLC's portfolio in Q2 2026, its #1636 holding.
  • Choreo LLC first reported a position in Iovance Biotherapeutics in Q2 2024 and has held it in 9 quarters since.
  • Choreo LLC's Iovance Biotherapeutics position peaked at $218K in Q4 2024.
  • 292 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.

Based on Choreo LLC's 13F filing for Q2 2026, filed 4 Aug 2026.